Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a newer software version has been applied to the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA minor update to the ClinicalTrials.gov interface version is reflected in the page footer, moving from revision v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 deleted.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page history.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded revision v3.4.3 to the history and removed revision v3.4.2.SummaryDifference0.1%

- Check113 days agoChange DetectedThe page history shows a new revision (v3.4.2) and removal of the previous revision (v3.4.1), indicating a minor platform update with no visible changes to study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.